Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

BACKGROUND: Refractory CMV viremia and disease are associated with significant morbidity and mortality in recipients of hematopoietic stem cell transplant (HCT). METHODS: In phase I/II trials, we treated 67 subjects for CMV viremia or disease arising after HCT with adoptive transfer of banked, third...

Descripción completa

Detalles Bibliográficos
Autores principales: Prockop, Susan E., Hasan, Aisha, Doubrovina, Ekaterina, Dahi, Parastoo B., Rodriguez-Sanchez, Irene, Curry, Michael, Mauguen, Audrey, Papanicolaou, Genovefa A., Su, Yiqi, Yao, JinJuan, Arcila, Maria, Boulad, Farid, Castro-Malaspina, Hugo, Cho, Christina, Curran, Kevin J., Giralt, Sergio, Kernan, Nancy A., Koehne, Guenther, Jakubowski, Ann, Papadopoulos, Esperanza, Perales, Miguel-Angel, Politikos, Ioannis, Price, Keith, Selvakumar, Annamalai, Sauter, Craig S., Tamari, Roni, Vizconde, Teresa, Young, James W., O’Reilly, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178844/
https://www.ncbi.nlm.nih.gov/pubmed/36951958
http://dx.doi.org/10.1172/JCI165476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178844/
https://www.ncbi.nlm.nih.gov/pubmed/36951958
http://dx.doi.org/10.1172/JCI165476

Ejemplares similares